Skinvisible's DermSafe Hand Sanitizer to Launch in Canada
Hand Sanitizer Made Without Alcohol Available Just in Time for Flu Season
LAS VEGAS, Aug. 18, 2011 (GLOBE NEWSWIRE) - Skinvisible Pharmaceuticals, Inc. (OTCQB:SKVI)
announced today that its DermSafe® antimicrobial hand sanitizer is being officially launched by Alto
Pharmaceuticals ("Alto") in Canada September 1st, just in time for the beginning of school and the flu season.
Alto, a Toronto-based dermatology focused company, has licensed the exclusive rights to DermSafe for
commercial use in Canada. Alto will market the product under the name DermSafePC.
About Alto Pharmaceuticals
With the World Health Organization (WHO) advocating proper hand hygiene as an important first-line
defense against the spread of the flu, the launch of DermSafe in Canada is very timely. DermSafe, developed
by Skinvisible with its patented Invisicare® delivery system, offers unique advantages over alcohol-based
hand sanitizers. DermSafe is made with 4% chlorhexidine gluconate, an ingredient used in hospitals
worldwide due to its effectiveness against a wide range of germs and its persistence. DermSafe hand sanitizer
lotion has no alcohol and therefore does not dry the skin like other sanitizers; instead it delivers protection in
a lotion formulation that defends the skin from outside irritants.
"We are pleased to see the launch of DermSafePC in Canada," said Terry Howlett, President and CEO of
Skinvisible. "Alto is committed to gaining market share quickly in Canada and we believe that the
introduction of DermSafePC will help generate a very positive response from end-users as well as potential
licensees worldwide." He added, "The manufacturing of DermSafe in Canada is critical to Skinvisible as it will
facilitate the quick introduction of the product in Europe and Singapore, where DermSafe is already approved
Alto will initially target institutions like schools, police forces, penitentiaries, etc. seeking for an alternative to
alcohol due to safety and long-term efficacy concerns. Outside of Canada, DermSafe is licensed in Europe,
where it recently received regulatory approval. A European launch is scheduled in the fourth quarter of
2011. Skinvisible continues to negotiate additional licenses for the retail (pharmacy) rights in Canada and
Europe, along with other parts of the world.
Alto Pharmaceuticals is a specialty pharmaceutical company focused on the development and
commercialization of unique products for maintaining a healthy lifestyle and improving quality of life. Alto's
areas of interest include Dermatology and Skin Care, Infectious Disease and Wound Care, and the company is
dedicated to bringing physicians, patients and consumers unique pharmaceutical products and devices. www.altopharma.com